These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 16567755)
41. The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review. van Gorkom GNY; Lookermans EL; Van Elssen CHMJ; Bos GMJ Nutrients; 2019 Apr; 11(5):. PubMed ID: 31035414 [TBL] [Abstract][Full Text] [Related]
43. [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma]. Nakagami Y; Lin TT; Ito H; Hirasawa S; Tannawa K; Fujioka Y; Ogawa H; Tanaka K; Yamada N; Ishii Y Hinyokika Kiyo; 1987 Oct; 33(10):1728-32. PubMed ID: 3128071 [TBL] [Abstract][Full Text] [Related]
44. The Emerging Role of Vitamin C as a Treatment for Sepsis. Kashiouris MG; L'Heureux M; Cable CA; Fisher BJ; Leichtle SW; Fowler AA Nutrients; 2020 Jan; 12(2):. PubMed ID: 31978969 [TBL] [Abstract][Full Text] [Related]
45. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. Creagan ET; Moertel CG; O'Fallon JR; Schutt AJ; O'Connell MJ; Rubin J; Frytak S N Engl J Med; 1979 Sep; 301(13):687-90. PubMed ID: 384241 [TBL] [Abstract][Full Text] [Related]
46. Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. Padayatty SJ; Sun AY; Chen Q; Espey MG; Drisko J; Levine M PLoS One; 2010 Jul; 5(7):e11414. PubMed ID: 20628650 [TBL] [Abstract][Full Text] [Related]
47. Effects of High Doses of Vitamin C on Cancer Patients in Singapore: Nine Cases. Raymond YC; Glenda CS; Meng LK Integr Cancer Ther; 2016 Jun; 15(2):197-204. PubMed ID: 26679971 [TBL] [Abstract][Full Text] [Related]
48. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis. St Peter WL; Li S; Liu J; Gilbertson DT; Arneson TJ; Collins AJ Pharmacotherapy; 2009 Feb; 29(2):154-64. PubMed ID: 19170585 [TBL] [Abstract][Full Text] [Related]
49. Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial. Choueiri TK; Larkin J; Oya M; Thistlethwaite F; Martignoni M; Nathan P; Powles T; McDermott D; Robbins PB; Chism DD; Cho D; Atkins MB; Gordon MS; Gupta S; Uemura H; Tomita Y; Compagnoni A; Fowst C; di Pietro A; Rini BI Lancet Oncol; 2018 Apr; 19(4):451-460. PubMed ID: 29530667 [TBL] [Abstract][Full Text] [Related]
50. Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure. Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y Circulation; 1998 Mar; 97(9):886-91. PubMed ID: 9521337 [TBL] [Abstract][Full Text] [Related]
51. Narrow scope of vitamin C review. Sardi W PLoS Med; 2005 Sep; 2(9):e308; author reply e309. PubMed ID: 16173839 [No Abstract] [Full Text] [Related]
53. Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency. Sultana T; DeVita MV; Michelis MF Int Urol Nephrol; 2016 Sep; 48(9):1519-24. PubMed ID: 27170339 [TBL] [Abstract][Full Text] [Related]
54. Serum ascorbic acid concentrations in previously unsupplemented greyhounds after administration of a single dose of ascorbic acid intravenously or per os. Scott KC; Hill RC; Lewis DD; Gronwall R; Sundstrom DA; Jones GL; Harper J J Anim Physiol Anim Nutr (Berl); 2002 Aug; 86(7-8):222-8. PubMed ID: 15379908 [TBL] [Abstract][Full Text] [Related]
55. Role of Vitamin C in Selected Malignant Neoplasms in Women. Markowska A; Antoszczak M; Markowska J; HuczyĆski A Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215535 [TBL] [Abstract][Full Text] [Related]
56. Appropriate vitamin D loading regimen for patients with advanced lung cancer. Hoffer LJ; Robitaille L; Swinton N; Agulnik J; Cohen V; Small D; Pepe C; Eintracht S Nutr J; 2016 Oct; 15(1):84. PubMed ID: 27716304 [TBL] [Abstract][Full Text] [Related]
57. A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma. Bates SE; Bakke S; Kang M; Robey RW; Zhai S; Thambi P; Chen CC; Patil S; Smith T; Steinberg SM; Merino M; Goldspiel B; Meadows B; Stein WD; Choyke P; Balis F; Figg WD; Fojo T Clin Cancer Res; 2004 Jul; 10(14):4724-33. PubMed ID: 15269145 [TBL] [Abstract][Full Text] [Related]
58. First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70. Owonikoko TK; Hussain A; Stadler WM; Smith DC; Kluger H; Molina AM; Gulati P; Shah A; Ahlers CM; Cardarelli PM; Cohen LJ Cancer Chemother Pharmacol; 2016 Jan; 77(1):155-62. PubMed ID: 26576779 [TBL] [Abstract][Full Text] [Related]
59. Effect of high-dose intravenous vitamin C on inflammation in cancer patients. Mikirova N; Casciari J; Rogers A; Taylor P J Transl Med; 2012 Sep; 10():189. PubMed ID: 22963460 [TBL] [Abstract][Full Text] [Related]
60. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]